Copiktra side effects by duration, gender and age - a phase IV clinical study of FDA data
Side effects are reported by people who take Copiktra. Common side effects include death among females and death among males.
The phase IV clinical study is created by eHealthMe based on 484 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
484 people who take Copiktra and have side effects are studied.
What is Copiktra?
Copiktra has active ingredients of duvelisib. eHealthMe is studying from 484 Copiktra users for its effectiveness, alternative drugs and more.
Number of Copiktra reports submitted per year:
Copiktra side effects by time on the drug *:
Copiktra side effects by gender *:
Copiktra side effects by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Copiktra?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on duvelisib (the active ingredients of Copiktra) and Copiktra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Alternative drugs to, pros and cons of Copiktra:
- Copiktra (484 reports)
Common Copiktra side effects:
- Diarrhea: 121 reports
All Copiktra side effects from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Viberzi and Disease Progression - 2 seconds ago
- Patanol and Bleeding Into The Skin - 7 seconds ago
- Perampanel and Hallucinations - 13 seconds ago
- Aimovig and Rogaine drug interaction - 21 seconds ago
- Carvedilol and Adempas drug interaction - 26 seconds ago
- Adenosine and Tivicay drug interaction - 28 seconds ago
- Flumadine and Lichen Planus Aggravated - 29 seconds ago
- Zofran and Promacta drug interaction - 30 seconds ago
- Paroxetine and Amniotic Cavity Infection - 30 seconds ago
- Loraz and Spider Naevus - 30 seconds ago